Bausch Health Companies Inc (BHC)
6.885
-0.06
(-0.94%)
USD |
NYSE |
May 10, 16:00
6.885
0.00 (0.00%)
After-Hours: 20:00
Bausch Health Cash from Financing (TTM): 1.277B for March 31, 2024
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 1.277B |
| December 31, 2023 | 1.475B |
| September 30, 2023 | 1.278B |
| June 30, 2023 | -574.00M |
| March 31, 2023 | -1.084B |
| December 31, 2022 | -474.00M |
| September 30, 2022 | 77.00M |
| June 30, 2022 | -1.044B |
| March 31, 2022 | -802.00M |
| December 31, 2021 | -1.513B |
| September 30, 2021 | -2.291B |
| June 30, 2021 | -1.251B |
| March 31, 2021 | -1.016B |
| December 31, 2020 | -2.294B |
| September 30, 2020 | 464.00M |
| June 30, 2020 | 107.00M |
| March 31, 2020 | 72.00M |
| December 31, 2019 | 1.443B |
| September 30, 2019 | -1.314B |
| June 30, 2019 | -1.226B |
| March 31, 2019 | -1.215B |
| December 31, 2018 | -1.353B |
| September 30, 2018 | -2.693B |
| June 30, 2018 | -3.737B |
| March 31, 2018 | -3.809B |
| Date | Value |
|---|---|
| December 31, 2017 | -4.963B |
| September 30, 2017 | -3.696B |
| June 30, 2017 | -2.963B |
| March 31, 2017 | -3.665B |
| December 31, 2016 | -1.963B |
| September 30, 2016 | -1.266B |
| June 30, 2016 | -698.60M |
| March 31, 2016 | 1.578B |
| December 31, 2015 | 13.62B |
| September 30, 2015 | 12.40B |
| June 30, 2015 | 11.45B |
| March 31, 2015 | 9.969B |
| December 31, 2014 | -2.46B |
| September 30, 2014 | -1.492B |
| June 30, 2014 | 1.908B |
| March 31, 2014 | 4.421B |
| December 31, 2013 | 4.028B |
| September 30, 2013 | 6.721B |
| June 30, 2013 | 4.395B |
| March 31, 2013 | 2.331B |
| December 31, 2012 | 3.057B |
| September 30, 2012 | 1.732B |
| June 30, 2012 | 2.039B |
| March 31, 2012 | 1.416B |
| December 31, 2011 | 1.948B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-2.294B
Minimum
Dec 2020
1.475B
Maximum
Dec 2023
-434.50M
Average
-688.00M
Median
Cash from Financing (TTM) Benchmarks
| Acasti Pharma Inc | 7.359M |
| Aurinia Pharmaceuticals Inc | -5.13M |
| Edesa Biotech Inc | 2.224M |
| Lexaria Bioscience Corp | 6.862M |
| Xenon Pharmaceuticals Inc | 353.52M |